Senior Field Medical Affairs Leader - Hematology/Oncology

Regeneron Pharmaceuticals, Inc (USA); United States; À distance; USD 176 000 - 287 000; Plein temps

Résumé du poste

Regeneron Pharmaceuticals, Inc. is seeking an Associate Director, Field Medical Affairs (Medical Science Liaison) to engage KOLs, HCPs, and researchers across Hematologic Malignancies, with a focus on NHL and Multiple Myeloma, in a high-travel territory in northern CA and Nevada.

The role drives scientific exchanges, supports investigator-initiated studies, and contributes to medical strategy while upholding regulatory standards. Travel about 70% and on-site engagement are required.

Qualifications

• Terminal scientific degree required.
• 8+ years experience with at least 4 years in MSL within Hematology/Oncology.
• Knowledge of FDA/pharma regulations and OIG guidelines.

Responsabilités

• Identifying and maintaining medical/therapeutic area experts and plans of action.
• Establishing and maintaining relationships with KOLs in Hematologic Malignancies.
• Serving as primary clinical/scientific resource for disease state and products.
• Participating in development and management of company sponsored clinical trials.
• Supporting investigator-initiated study (IIS) concept program.
• Identifying insights on research developments to shape medical strategy.
• Responding to requests for information related to study indications, disease state and therapeutic area, and presenting/discussing scientific/clinical data.
• Attending medical conferences collecting and reporting relevant, scientific, clinical, & competitive intelligence.
• Ensuring company policies, procedures, principles and financial controls are maintained with integrity and professionalism.

Connaissances

KOL relationship management

Medical affairs leadership

Clinical trial support

Scientific communication

Formation

MD/PhD/PharmD/DNP/DVM

Description du poste

Regeneron Pharmaceuticals, Inc. is seeking an Associate Director, Field Medical Affairs (Medical Science Liaison) to engage KOLs, HCPs, and researchers across Hematologic Malignancies, with a focus on NHL and Multiple Myeloma, in a high-travel territory in northern CA and Nevada.

The role drives scientific exchanges, supports investigator-initiated studies, and contributes to medical strategy while upholding regulatory standards. Travel about 70% and on-site engagement are required.